🇺🇸 FDA
Pipeline program

SHR2554/AZA + Overlapped TBF

20260414125804551

Phase 2 other active

Quick answer

SHR2554/AZA + Overlapped TBF for Acute Myeloid Leukemia is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Acute Myeloid Leukemia
Phase
Phase 2
Modality
other
Status
active

Clinical trials